Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2003 1
2007 1
2008 2
2010 1
2011 1
2013 2
2014 1
2015 3
2016 2
2017 1
2018 1
2019 3
2020 1
2021 1
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Diet Advice for Crohn's Disease: FODMAP and Beyond.
Popa SL, Pop C, Dumitrascu DL. Popa SL, et al. Among authors: pop c. Nutrients. 2020 Dec 6;12(12):3751. doi: 10.3390/nu12123751. Nutrients. 2020. PMID: 33291329 Free PMC article. Review.
Notwithstanding the evidence, it remains to be established if an LFD is more efficient than other types of diets in the short term and especially in the long term....
Notwithstanding the evidence, it remains to be established if an LFD is more efficient than other types of diets in the short term an …
Edoxaban versus warfarin in patients with atrial fibrillation.
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Giugliano RP, et al. N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251359 Free article. Clinical Trial.
BACKGROUND: Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known. ...
BACKGROUND: Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of ed …
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.
Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJ; ODYSSEY LONG TERM Investigators. Robinson JG, et al. N Engl J Med. 2015 Apr 16;372(16):1489-99. doi: 10.1056/NEJMoa1501031. Epub 2015 Mar 15. N Engl J Med. 2015. PMID: 25773378 Free article. Clinical Trial.
BACKGROUND: Alirocumab, a monoclonal antibody that inhibits proprotein convertase subtilisin-kexin type 9 (PCSK9), has been shown to reduce low-density lipoprotein (LDL) cholesterol levels in patients who are receiving statin therapy. Larger and longer-term studies are nee …
BACKGROUND: Alirocumab, a monoclonal antibody that inhibits proprotein convertase subtilisin-kexin type 9 (PCSK9), has been shown to reduce …
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
BACKGROUND: Two glucagon-like peptide-1 (GLP-1) receptor agonists reduced renal outcomes in people with type 2 diabetes at risk for cardiovascular disease. We assessed the long-term effect of the GLP-1 receptor agonist dulaglutide on renal outcomes in an exploratory analys …
BACKGROUND: Two glucagon-like peptide-1 (GLP-1) receptor agonists reduced renal outcomes in people with type 2 diabetes at risk for cardiova …
The Effect of Polyphenols, Minerals, Fibers, and Fruits on Irritable Bowel Syndrome: A Systematic Review.
Chiarioni G, Popa SL, Ismaiel A, Pop C, Dumitrascu DI, Brata VD, Duse TA, Incze V, Surdea-Blaga T. Chiarioni G, et al. Among authors: pop c. Nutrients. 2023 Sep 20;15(18):4070. doi: 10.3390/nu15184070. Nutrients. 2023. PMID: 37764853 Free PMC article. Review.
However, due to the heterogeneity of the included studies and the limited number of high-quality randomized controlled trials, further well-designed trials are warranted to establish the optimal dosages, duration, and long-term effects of these interventions. Understanding …
However, due to the heterogeneity of the included studies and the limited number of high-quality randomized controlled trials, further well- …
Benefits and Risks of Anticoagulation in Acute Coronary Syndrome.
Pop C, Matei C. Pop C, et al. Am J Ther. 2019 Mar/Apr;26(2):e198-e207. doi: 10.1097/MJT.0000000000000915. Am J Ther. 2019. PMID: 30839368 Review.
The choice is particularly important for special categories of patients with ACS who have an indication of a long-term OAC. DATA SOURCES: A literature search regarding benefits and risks of anticoagulation in ACS was conducted through MEDLINE and EMBASE (past 20 years unti …
The choice is particularly important for special categories of patients with ACS who have an indication of a long-term OAC. DATA SOUR …
The functional sphincter of Oddi disorder.
Pop C, Purcăreanu A, Purcărea M, Andronescu D. Pop C, et al. J Med Life. 2008 Apr-Jun;1(2):118-29. J Med Life. 2008. PMID: 20108458 Free PMC article. Review.
For a better understanding, the American Gastroenterology Association Institute created a new classification of The Functional Gastrointestinal Disorders in 2006, Rome III Classification, in which the SOD is grouped in the functional biliary disorders (category E). The term …
For a better understanding, the American Gastroenterology Association Institute created a new classification of The Functional Gastrointesti …
Anticoagulation in Acute Coronary Syndrome: Review of Major Therapeutic Advances.
Pop C, Matei C, Petris A. Pop C, et al. Am J Ther. 2019 Mar/Apr;26(2):e184-e197. doi: 10.1097/MJT.0000000000000913. Am J Ther. 2019. PMID: 30839367 Review.
Thus, the overall benefit of adding NOAC to antiplatelet treatment after ACS in patients without clear indication for long-term OAC is still unknown. CONCLUSIONS: Different OACs have been tested as antithrombotic therapy after ACS in combination with single or DAPT and led …
Thus, the overall benefit of adding NOAC to antiplatelet treatment after ACS in patients without clear indication for long-term OAC i …
Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry.
Kerneis M, Cosentino F, Ferrari R, Georges JL, Kosmachova E, Laroche C, Maggioni AP, Rittger H, Steg PG, Maczynska J, Tavazzi L, Valgimigli M, Gale CP, Komajda M; CICD investigators group. Kerneis M, et al. Eur J Prev Cardiol. 2022 Nov 8;29(15):1945-1954. doi: 10.1093/eurjpc/zwac089. Eur J Prev Cardiol. 2022. PMID: 35653582 Free article.
The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Chronic Ischemic Cardiovascular Disease Long-Term (CICD-LT) registry is a prospective European registry, and was designed to describe the profile, management, and outcomes of patients with …
The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Chronic Ischemic Cardiovascular Disease Long-Term …
The ESC-EORP Chronic Ischaemic Cardiovascular Disease Long Term (CICD LT) registry.
Komajda M, Cosentino F, Ferrari R, Laroche C, Maggioni A, Steg PG, Tavazzi L, Kerneis M, Valgimigli M, Gale CP; CICD Investigators Group. Komajda M, et al. Eur Heart J Qual Care Clin Outcomes. 2021 Jan 25;7(1):28-33. doi: 10.1093/ehjqcco/qcz057. Eur Heart J Qual Care Clin Outcomes. 2021. PMID: 31605146
AIMS: The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Chronic Ischaemic Cardiovascular Disease Long Term (CICD LT) registry aims to study the clinical profile, treatment modalities, and outcomes of patients diagnosed with CICD in a conte …
AIMS: The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Chronic Ischaemic Cardiovascular Disease Long T …
26 results